Clinical Trials Update:&nbsp;Dec. 29, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
769840
BALTIMORE -- British researchers have begun human trials to investigate a vaccine that could possibly cure type 1 diabetes. Meanwhile, overindulging in food during the holiday season can pose dangerous health risks for type 2 diabetics.
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
527274
roundup Plus: PMC-Sierra lowers forecast...WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
554707
NEWS: In 2002, weeks before President Bush announced a plan to protect African babies from AIDS, top US health officials were warned that research about the drug, nevirapine, was flawed
422394
Search headlines from around the web, December 29, 2004.
603771
roundup Plus: Shopping.com holders cut IPO shares...Transmeta starts new chip, warns on earnings...Keynote to buy researcher Vividence.
362077
Clinical trial data released by pharmaceutical company Boehringer Ingelheim at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, on its experimental protease inhibitor tipranavir show that the drug is effective
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
552158
It can be incredibly difficult for patients to ferret out studies of experimental drugs that offer hope to threat their disease. There is no comprehensive database of ongoing clinical trials, but specialists offer advice for the search:
371936
roundup Plus: Siebel moves toward self-repairing software...Monster says it could enter Japan by mid-2005...Novell to release Open Enterprise Server.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
388692
roundup Plus: PeopleSoft-Oracle trial delayed...IBM, Boeing team up for defense work...TI touts combo chip with VoIP, Wi-Fi...ContextWeb nabs $3 million.